RBC Capital analyst Anke Reingen maintained a Buy rating on UBS Group AG (UBS – Research Report) today and set a price target of CHF36.00. The ...

RBC Capital analyst Biraj Borkhataria maintained a Hold rating on Equinor ASA (0M2Z – Research Report) yesterday and set a price target of ...

CEO Sergio Ermotti highlighted the strong fourth-quarter and full-year 2024 performance, with a net profit of $5.1 billion and underlying return on CET1 capital of 8.7%. Ermotti emphasized the ...

The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

Find insight on Suncor Energy, Petronas, Orsted, and more in the latest Market Talks covering Energy and Utilities.

DJIA stocks to watch today. Market trends show gains in retail, tech, and energy. Get insights on Walmart, Apple, Amazon, and more!

Management projects 2025 revenue between $6.085 billion and $6.245 billion, with organic growth at 5% at the midpoint. Adjusted EPS for the full year is expected to range from $5.64 to $5.96.

Wall Street traders trying to catch up on every new headline around President Donald Trump’s tariff negotiations were faced with a renewed bout of volatility across asset classes.

Wall Street traders trying to catch up on every new headline around President Donald Trump’s tariff negotiations were faced with a renewed bout of volatility across asset classes.

Wall Street traders trying to catch up on every new headline around President Donald Trump’s tariff negotiations were faced with a renewed bout of volatility across asset classes.

Olin (NYSE:OLN – Free Report) had its target price lowered by UBS Group from $35.00 to $34.00 in a research note published on Friday morning,Benzinga reports. UBS Group currently has a neutral rating ...

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target hoisted by equities researchers at UBS Group from $162.00 to $176.00 in a research note issued to investors on ...